ArticleNagoya journal of medical science2022
Initial experience of tofacitinib for treating refractory moderate-to-severe ulcerative colitis.
Masanao Nakamura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2022
this papercites it